Dallas, TX -- (SBWIRE) -- 10/13/2014 -- Clinical trial report, “Behcet’s Disease Global Clinical Trials Review, H2, 2014? provides data on the Behcet’s Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Behcet’s Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Behcet’s Disease.

Behçet's disease or Behçet disease sometimes called Behçet's syndrome, Morbus Behçet, Behçet-Adamantiades syndrome, or Silk Road disease, is a rare immune-mediated small-vessel systemic vasculitis that often presents with mucous membrane ulceration and ocular problems. Behçet's disease (BD) was named in 1937 after the Turkish dermatologist Hulusi Behçet, who first described the triple-symptom complex of recurrent oral aphthous ulcers, genital ulcers, and uveitis. As a systemic disease, it can also involve visceral organs such as the gastrointestinal tract, pulmonary, musculoskeletal, cardiovascular and neurological systems. This syndrome can be fatal due to ruptured vascular aneurysms or severe neurological complications.

Complete Report Details @ http://www.marketoptimizer.org/behcets-disease-global-clinical-trials-review-h2-2014.html .

Scope:

-Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations

-Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

-Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to Buy:

-Understand the dynamics of a particular indication in a condensed manner

-Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

-Obtain discontinued trial listing for trials across the globe

-Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Order a Purchase copy
http://www.marketoptimizer.org/contacts/purchase?rname=11435

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Behcet’s Disease 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Behcet’s Disease to Immunology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Behcet’s Disease to Immunology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Behcet’s Disease 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Behcet’s Disease Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
XOMA Corporation 32
Clinical Trial Overview of XOMA Corporation 32
AbbVie Inc. 33
Clinical Trial Overview of AbbVie Inc. 33
Novartis AG 34
Clinical Trial Overview of Novartis AG 34
Celgene Corporation 35
Clinical Trial Overview of Celgene Corporation 35
Nobelpharma Co., Ltd. 36
Clinical Trial Overview of Nobelpharma Co., Ltd. 36
Mitsubishi Chemical Holdings Corporation 37
Clinical Trial Overview of Mitsubishi Chemical Holdings Corporation 37
Les Laboratoires Servier SAS 38
Clinical Trial Overview of Les Laboratoires Servier SAS 38
Clinical Trial Overview of Top Institutes / Government 39
Tehran University of Medical Sciences 39
Clinical Trial Overview of Tehran University of Medical Sciences 39
National Institute of Arthritis and Musculoskeletal and Skin Diseases 40
Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases 40
New York University School of Medicine 41
Clinical Trial Overview of New York University School of Medicine 41
University Hospital Tubingen 42
Clinical Trial Overview of University Hospital Tubingen 42
National Eye Institute 43
Clinical Trial Overview of National Eye Institute 43
Cukurova University 44
Clinical Trial Overview of Cukurova University 44
Erasmus MC 45
Clinical Trial Overview of Erasmus MC 45
Rambam Health Care Campus 46
Clinical Trial Overview of Rambam Health Care Campus 46
Shiraz University of Medical Sciences 47
Clinical Trial Overview of Shiraz University of Medical Sciences 47
Asan Medical Center 48
Clinical Trial Overview of Asan Medical Center 48
Five Key Clinical Profiles 49
Appendix 77
Abbreviations 77
Definitions 77
Research Methodology 78
Secondary Research 78
About GlobalData 79
Contact Us 79
Disclaimer 79
Source 80

Browse more reports on Clinical Trial Market
http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/clinical-trial